Physician profile
Ian Johnston
NPI 1679551345
$4,392.77
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,450 · 2020: $231 · 2021: $513 · 2023: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $1,628.87 | 2019 | |
| Minerva Surgical, INC | $1,500.00 | 2019 | |
| Abbvie INC. | $696.18 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $113.22 | 2023 | |
| Agile Therapeutics, INC. | $105.38 | 2021 | |
| Astellas Pharma US INC | $98.75 | 2020-2023 | Veozah |
| Merck Sharp & Dohme LLC | $69.34 | 2019-2021 | |
| Pfizer INC. | $49.54 | 2020-2021 | |
| Evofem Biosciences, INC. | $38.29 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.80 | 2019-2020 | |
| Sage Therapeutics, LLC | $14.04 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.07 | 2020 | |
| Exeltis, USA INC. | $13.05 | 2020 | |
| Organon LLC | $12.75 | 2021 | |
| Hologic Sales and Service, LLC | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.